The PTPN22 gene, crucial in T-cell receptor signaling, is notably associated with increased risk for rheumatic diseases like RA, SLE, and juvenile idiopathic arthritis (JIA). This evidence concerns the gene PTPN22 and systemic lupus erythematosus.